Co-Authors
This is a "connection" page, showing publications co-authored by Mark Mulligan and Ajay Nirula.
Connection Strength
0.121
-
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19. Clin Pharmacol Ther. 2021 12; 110(6):1467-1477.
Score: 0.061
-
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA. 2021 07 06; 326(1):46-55.
Score: 0.060